Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Leishmaniasis D007896 19 associated lipids
Influenza, Human D007251 11 associated lipids
Hypertension D006973 115 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hemolysis D006461 131 associated lipids
Gonorrhea D006069 7 associated lipids
Dermatomycoses D003881 17 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Fernández-Campos F et al. Evaluation of novel nystatin nanoemulsion for skin candidosis infections. 2013 Mycoses pmid:22574899
Perez R et al. The effect of topically applied antimycotic agents on inner ear vestibular and cochlear function. 2013 Laryngoscope pmid:22991276
Godoy JS et al. Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis. 2013 J. Oral Pathol. Med. pmid:22978344
Silva S et al. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic. 2013 Med. Mycol. pmid:22803822
Pinelli LA et al. Ricinus communis treatment of denture stomatitis in institutionalised elderly. 2013 J Oral Rehabil pmid:23438045
Kim DH et al. Differential regulation of CC chemokine ligand 2 and CXCL8 by antifungal agent nystatin in macrophages. 2013 Biochem. Biophys. Res. Commun. pmid:23831464
Melkoumov A et al. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans. 2013 J. Antimicrob. Chemother. pmid:23620465
Kanlaya R et al. Macropinocytosis is the major mechanism for endocytosis of calcium oxalate crystals into renal tubular cells. 2013 Cell Biochem. Biophys. pmid:23695784
Chen Y et al. Antifungal mechanism of essential oil from Anethum graveolens seeds against Candida albicans. 2013 J. Med. Microbiol. pmid:23657528
Manzoni P et al. Prevention of nosocomial infections in neonatal intensive care units. 2013 Am J Perinatol pmid:23292914
Ouyang W et al. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells. 2013 Int. J. Oncol. pmid:23258590
Siljamäki E et al. Cholesterol dependence of collagen and echovirus 1 trafficking along the novel α2β1 integrin internalization pathway. 2013 PLoS ONE pmid:23393580
Daneman N et al. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. 2013 Lancet Infect Dis pmid:23352693
Shi L et al. Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. 2013 Nat Commun pmid:23385580
Hu R et al. Prospective trial finds nystatin mouthwash effective prophylaxis for pulmonary invasive fungal infections that originate in the throat of patients with hematologic malignancies. 2013 Neoplasma pmid:23374002
Kumano-Kuramochi M et al. Lectin-like oxidized LDL receptor-1 is palmitoylated and internalizes ligands via caveolae/raft-dependent endocytosis. 2013 Biochem. Biophys. Res. Commun. pmid:23583401
Austin N et al. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. 2013 Cochrane Database Syst Rev pmid:23543519
Martín-Villena MJ et al. Novel microparticulate systems for the vaginal delivery of nystatin: development and characterization. 2013 Carbohydr Polym pmid:23544502
Pál S et al. Technological and biopharmaceutical optimization of nystatin release from a multiparticulate based bioadhesive drug delivery system. 2013 Eur J Pharm Sci pmid:23528741
Wang W et al. The interaction of polysaccharide from Auricularia polytricha with quantum dots and the protection of plasmid DNA from damage. 2013 Appl. Biochem. Biotechnol. pmid:23440638
Demirel G et al. Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants. 2013 Eur. J. Pediatr. pmid:23703468
Monteiro DR et al. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. 2013 Mycoses pmid:23773119
El-Wahidi M et al. [Bio-guided isolation of an antifungal from Haliclona enamela collected from Jorf Lasfar port, Morocco]. 2013 J Mycol Med pmid:23726234
Gerstein AC Mutational effects depend on ploidy level: all else is not equal. 2013 Biol. Lett. pmid:23054913
Lin TY et al. Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. 2013 Cell Rep pmid:24268777
Chen Z et al. [The clinical research of nystatin in prevention of invasive fungal infections in patients on mechanical ventilation in intensive care unit]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24021043
Reis DC et al. Structural studies and investigation on the activity of imidazole-derived thiosemicarbazones and hydrazones against crop-related fungi. 2013 Molecules pmid:24129274
Tugizov SM et al. Epstein-Barr virus transcytosis through polarized oral epithelial cells. 2013 J. Virol. pmid:23698302
Maroszyńska M et al. Antibiotics sensitivity of Candida clinical and food-borne isolates. 2013 Acta Biochim. Pol. pmid:24432323
Ceccarelli G et al. Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation. 2013 Crit Care pmid:23414732
Hothersall JD et al. Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization. 2013 Br. J. Pharmacol. pmid:23581504
Bosanquet DC et al. Topical steroids for chronic wounds displaying abnormal inflammation. 2013 Ann R Coll Surg Engl pmid:23676816
Milton Rocha Gusmão J and Pereira RP Treatment protocol for denture stomatitis, prior to anatomical molding. 2013 Gerodontology pmid:22506854
Heneedak HM et al. HPLC and chemometric methods for the simultaneous determination of miconazole nitrate and nystatin. 2012 Nov-Dec J Chromatogr Sci pmid:22879356
Alcântara CS et al. Peel bond strength of resilient liner modified by the addition of antimicrobial agents to denture base acrylic resin. 2012 Nov-Dec J Appl Oral Sci pmid:23329241
Houlton JJ et al. Intranasal drug-induced fungal rhinopharyngitis. 2012 Mar-Apr Int Forum Allergy Rhinol pmid:22253034
Kaufman DA "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants. 2012 Early Hum. Dev. pmid:22633513
Shanmughapriya S et al. In vitro actinomycete biofilm development and inhibition by the polyene antibiotic, nystatin, on IUD copper surfaces. 2012 Biofouling pmid:22963125
Blyth CC et al. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. 2012 J Paediatr Child Health pmid:22970680
Silva MM et al. Comparison of denture microwave disinfection and conventional antifungal therapy in the treatment of denture stomatitis: a randomized clinical study. 2012 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22986242
Kaomongkolgit R et al. Antifungal activity of coronarin D against Candida albicans. 2012 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22727093
Fernández Campos F et al. Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies. 2012 J Pharm Sci pmid:22777575
Al-Dwairi ZN et al. The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans. 2012 J Prosthodont Res pmid:22841909
Caliceti C et al. Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells. 2012 PLoS ONE pmid:22859971
Kondo C et al. Predictive genomic biomarkers for drug-induced nephrotoxicity in mice. 2012 J Toxicol Sci pmid:22863853
Ouédraogo M et al. Free radical scavenging capacity, anticandicidal effect of bioactive compounds from Sida cordifolia L., in combination with nystatin and clotrimazole and their effect on specific immune response in rats. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:23268761
Kovac M et al. Miconazole and nystatin used as topical antifungal drugs interact equally strongly with warfarin. 2012 J Clin Pharm Ther pmid:21332566
da Silva WJ et al. Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents. 2012 Braz Dent J pmid:23338267
Seipke RF et al. Isolating antifungals from fungus-growing ant symbionts using a genome-guided chemistry approach. 2012 Meth. Enzymol. pmid:23084933
Shinde RB et al. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:23035934